Acidif plus food supplement 14 tablets

aci d if _plus Food supplement based on L-methionine, dry extract of Ibiscus sabdariffa flowers (UTIROSE - Burgundy) and dry extract of Boswellia serrata leaves (AKBAMAX) titrated at 10% in acetyl keto beta boswellic acids (AKBA ). Thanks to its components, it helps to promote the correct functionality of the urinary system, creating unfavorable conditions for bacterial development and proliferation. Acidif plus is presented in retard gastroprotected tablets with gradual release. This optimizes tolerability and guarantees a constant release of its components over time.
L-Methionine
L-Methionine is part of the essential amino acids and, as such, is an important constituent of the human body. L-Methionine, which our body is unable to produce, but must be introduced from the outside, is the only essential amino acid that contains sulfur in its formula. The availability of L-Methionine (as a sulfur donor) in sufficient quantity is the necessary condition for the biosynthesis of cysteine, a sulphured amino acid. A large number of Gram-negative bacteria is able to alkalize the urine by enzymatic degradation of urea, thus determining favorable growth conditions for them. The maintenance of a physiological pH obtained by the action of L-methionine, manages to create unfavorable conditions for bacterial colonization.
Ibiscus sabdariffa
Recent studies have shown that UTIROSE Ibiscus sabdariffa dry extract titrated at 40% in Organic Acids and 50% in Sambubiosides shows a significant effect on the reduction of an initial microbial contamination by both E.coli and Candida albicans. In fact, the particular UTIROSE phytocomplex, characterized by the presence of two molecular components such as Sambubiosides, specific proanthocyanidins, and the characteristic organic acids, has been tested for its effects on the urinary tract. The results obtained show a 77% reduction in infections due to an antimicrobial activity which manifests itself already after one week of treatment.
Boswellia serrata
The international scientific literature shows that AKBAMAX - Boswellia serrata gum resin dry extract is able to inhibit some inflammatory mediators, in particular 5-lipoxygenase, with a consequent decrease in the inflammatory response from leukotrienes. By acting on this enzyme, and not on the cyclooxygenases (COX1, COX2) responsible for the synthesis of prostaglandins, prostacyclines and thromboxanes, also with proinflammatory activity, the extract titrated in acetyl keto beta boswellic acid is considered to be one of the most natural anti-inflammatories. safe from a toxicological point of view.

Ingrediants

	for 1 tablet (1,000 mg)
L-Methionine	400 mg
Ibiscus sabdariffa flowers dry extract (UTIROSE-Burgundy)	100 mg
Boswellia serrata gum resin dry extract (AKBAMAX) equal acetyl keto beta boswellic acid (AKBA)	100 mg 10 mg

How to use
We recommend taking one tablet twice a day: 1 tablet in the evening before going to bed and 1 tablet in the morning upon awakening.

Warnings
Do not exceed the recommended daily dose.
Keep out of the reach of children under three years of age.
Supplements are not intended as a substitute for a varied diet.
For pregnant or lactating women and children it is recommended to seek medical advice.

Format
Box of 14 slow-release tablets of 1000 mg.

Code 01018

Bibliography
- S.Carlsson et al. - Effect of pH, nitrite and ascorbic acid on nonenzymatic nitric oxide generation and bacterial growth in urine - Nitric Oxide: Biology and Chemistry; Vol. 5, no.6, 580-586 (2001).
- Funfstuck R. - Prevention of reinfection by L-methionine in patients with recurrent urinary tract infection Med.Klin. Vol. 92, n.10, 574-81 (1997).
- K. Jarrar et al. - Struvite stones: long term follow up under metaphylaxis - Ann.Urol .; 30, n.3, 112-117 (1996).
- Ammon, HPT et al. (1993) Mechanism of anti-inflammatory actions of curcumin and boswellic acids, J. Ethnopharmacology, 38, 113-119.
- Opdyke DLJ (1978) Fragrance raw material monograph, olibanum gum. Fd. Cosmet. Toxicol., 16.837.
- Safayfi et al., 1992. Boswellic acids: novel, specific, non-redox inhibitors of 5-LO. J Pharmacol Exp. Ther 261 1143-46.
- Internal Report 2008 - Burgundy.